Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention
Author(s) -
Remo H.M. Furtado,
Antônio Fagundes,
Kazuma Oyama,
Thomas A. Zelniker,
Minao Tang,
Julia Kuder,
Sabina A. Murphy,
Andrew Hamer,
Huei Wang,
Anthony Keech,
Robert P. Giugliano,
Marc S. Sabatine,
Brian A. Bergmark
Publication year - 2022
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.121.011382
Subject(s) - medicine , cardiology , mace , percutaneous coronary intervention , conventional pci , myocardial infarction , evolocumab , hazard ratio , cholesterol , lipoprotein , confidence interval , apolipoprotein a1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom